September 01, 2026
Law360 Healthcare Authority looks at a Fifth Circuit ruling backing the removal of certain GLP-1 medications from the national drug shortage list, the dismissal of AstraZeneca's challenge to a Colorado law affecting drug distribution under the federal 340B drug discount program and other litigation outcomes impacting the healthcare industry.
March 30, 2026
A Fifth Circuit panel pushed multiple compounding pharmacies to explain why they should get to compound lucrative drugs used for weight loss, including Ozempic, saying Monday that its options if it sides with the pharmacies are "tough pills to swallow."